Home > Drug Search >
  • company_query: AmpliPhi Biosciences Corporation
  •   > 
Drug Filter
Category:
chemistry (19) biology (31)
Status:
Approved (5) Phase Ⅲ (7) Phase Ⅱ (26) Phase Ⅰ (12)
Clinical Stage:
Pending (4) Active (26) Discontinued (15)
Bio-Type:
Gene therapy (5) Cell therapy (1) Vaccine (20) Whole antibody (2)
Indication:
Alcohol dependence (1) Alzheimer's disease (AD) (1) Anxiety (1) Benign prostatic hypertrophy (1) Mercury poisoning (1) lead poisoning (1) Breast cancer (2) Bronchiectasis (1) Wiskott-Aldrich syndrome (1) Cystic fibrosis (CF) (1) Deep vein thrombosis (DVT) (1) Epilepsy/Seizures (2) Female sexual dysfunction (1) Gastric ulcer (1) Cytomegalovirus infections (1) HBV infection (1) HIV infection (3) Pulmonary alveolar proteinosis (1) Influenza virus infection (3) Leukemia (1) Lung cancer (1) Melanoma (1) Multiple myeloma (MM) (1) Ovarian cancer (1) Overactive bladder (OAB) (4) Pancreatic cancer (1) Parkinson's disease (PD) (1) Pneumonia (1) Prostate cancer (1) Poliomyelitis (1) Psoriasis (1) Pulmonary embolism (1) Chronic granulomatous disease (1) Solid tumours (2) Leber congenital amaurosis (1) Urinary incontinence (2) Urinary tract infections (1) Rhabdomyosarcoma (1) Head and neck cancer (1) Limb girdle muscular dystrophy (1) Hodgkin lymphoma (1) Colorectal cancer (1) Gestational trophoblastic disease (1) Nonseminomatous testicular cancer (1) Wilms Tumor (1) Malaria (4) Type 1 diabetes (1) Pruritus (1) Glioblastoma (2) Graft versus host disease (1) Ewing's Sarcoma (1) Cough (1) Ebola virus disease (EVD) (1) Respiratory distress syndrome (1) Urination disorders (1) Dental Caries (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top